Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 12
1 December 2003
Issue Cover
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer
Adam Kashishian; Heather Douangpanya; Darcey Clark; Stephen T. Schlachter; C. Todd Eary; Justin G. Schiro; Hongmei Huang; Larry E. Burgess; Edward A. Kesicki; James Halbrook
View articletitled, DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer
Open the PDF for in another window
Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
Curtis D. Hose; Melinda Hollingshead; Edward A. Sausville; Anne Monks
View articletitled, Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: A potential surrogate marker for patient sensitivity
Open the PDF for in another window
Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
Roberto R. Rosato; Jorge A. Almenara; Yun Dai; Steven Grant
View articletitled, Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells
Open the PDF for in another window
Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Arindam Dhar; June M. Brindley; Cristi Stark; Michael L. Citro; Larry K. Keefer; Nancy H. Colburn
View articletitled, Nitric oxide does not mediate but inhibits transformation and tumor phenotype
Open the PDF for in another window
Inhibition of tumor growth by a novel approach: In situ allicin generation using targeted alliinase delivery
Talia Miron; Marina Mironchik; David Mirelman; Meir Wilchek; Aharon Rabinkov
View articletitled, Inhibition of tumor growth by a novel approach: <em>In situ</em> allicin generation using targeted alliinase delivery
Open the PDF for in another window
Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
Stéphane Honore; Kathy Kamath; Diane Braguer; Leslie Wilson; Claudette Briand; Mary Ann Jordan
View articletitled, Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation
Open the PDF for in another window
E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model
Zhichao Zhou; Rong-Rong Zhou; Hui Guan; Corazon D. Bucana; Eugenie S. Kleinerman
View articletitled, <em>E1A</em> gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model
Open the PDF for in another window
Hematopoietic expression of O6-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O6-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea
Emiko L. Kreklau; Karen E. Pollok; Barbara J. Bailey; Naili Liu; Jennifer R. Hartwell; David A. Williams; Leonard C. Erickson
View articletitled, Hematopoietic expression of <em>O</em><sup>6</sup>-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination <em>O</em><sup>6</sup>-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea
Open the PDF for in another window
Antitumor activity of the novel melphalan containing tripeptide J3 (l-prolyl-l-melphalanyl-p-l-fluorophenylalanine ethyl ester): Comparison with its m-l-sarcolysin analogue P2
Joachim Gullbo; Charlotta Wallinder; Marcus Tullberg; Henrik Lövborg; Hans Ehrsson; Rolf Lewensohn; Peter Nygren; Kristina Luthman; Rolf Larsson
View articletitled, Antitumor activity of the novel melphalan containing tripeptide J3 (<span class="small-caps">l</span>-prolyl-<span class="small-caps">l</span>-melphalanyl-<em>p</em>-<span class="small-caps">l</span>-fluorophenylalanine ethyl ester): Comparison with its <em>m</em>-<span class="small-caps">l</span>-sarcolysin analogue P2
Open the PDF for in another window
Targeted delivery of human pro-apoptotic enzymes to tumor cells: In vitro studies describing a novel class of recombinant highly cytotoxic agents
Yuying Liu; Lawrence H. Cheung; Walter N. Hittelman; Michael G. Rosenblum
View articletitled, Targeted delivery of human pro-apoptotic enzymes to tumor cells: <em>In vitro</em> studies describing a novel class of recombinant highly cytotoxic agents
Open the PDF for in another window
Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon
Shuichi Taniguchi; Yasushi Mochida; Takeshi Uchiumi; Tomoko Tahira; Kenshi Hayashi; Koichi Takagi; Mitsuo Shimada; Yoshihiko Maehara; Hiroyuki Kuwano; Suminori Kono; Hitoo Nakano; Michihiko Kuwano; Morimasa Wada
View articletitled, Genetic polymorphism at the 5′ regulatory region of multidrug resistance 1 (<em>MDR1</em>) and its association with interindividual variation of expression level in the colon
Open the PDF for in another window
Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Ramzi M. Mohammad; Ayad Al-Katib; Amro Aboukameel; Daniel R. Doerge; Fazlul Sarkar; Omer Kucuk
View articletitled, Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Open the PDF for in another window
Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells
Yoon-Pin Lim; Lang-Shi Diong; Robert Qi; Brian J. Druker; Richard J. Epstein
View articletitled, Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells
Open the PDF for in another window

Acknowledgment to Reviewers

Acknowledgment to Reviewers
View articletitled, Acknowledgment to Reviewers
Open the PDF for in another window

Author Index

Author Index
View articletitled, Author Index
Open the PDF for in another window

Subject Index

Subject Index Volume 2
View articletitled, Subject Index Volume 2
Open the PDF for in another window

Advertisement

Breaking
E-cigarette Use Drops Dramatically among Kids
The NCI Calls for $11.446 Billion in Funding for FY 2026
Changes at the Top for Dana-Farber
View more recent articles
Latest News
Reprogramming Turns Cancer Cells into Immune Allies
With Vorasidenib, Glioma Treatment Continues Evolving
Cancer Research on The Ballot: Moonshot and the Future of Oncology Priorities
View more recent articles
Research Watch
X Chromosome Translocations Drive Sex Bias in a Rare Kidney Cancer Subtype
PIK3CA Mutations and Metabolic Conditions Drive Clonal Expansion in Normal Esophagus
Macrophages Scavenge Myelin to Support Glioblastoma Metabolism
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept